Relation between cholinesterase inhibitor and Pisa syndrome

被引:60
作者
Kwak, YT
Han, IW
Baik, J
Koo, MS
机构
[1] Yong In Hyoja Geriatr Hosp, Dept Neurol, Kyeongki Do 449910, South Korea
[2] Yonsei Univ, Coll Med, Dept Psychiat, Seoul 120749, South Korea
关键词
D O I
10.1016/S0140-6736(00)02412-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report two patients who developed Pisa syndrome after treatment with cholinesterase inhibitors-cognition-enhancing navel agents for patients with Alzheimer's disease. Cholinergic excess could be another factor in Pisa syndrome, especially in cholinergically-imbalanced Alzheimer's disease.
引用
收藏
页码:2222 / 2222
页数:1
相关论文
共 4 条
[1]   NEW DYSTONIC SYNDROME ASSOCIATED WITH BUTYROPHENONE THERAPY [J].
EKBOM, K ;
LJUNGBERG, L ;
LINDHOLM, H .
ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (02) :94-+
[2]   THE PISA SYNDROME - POSSIBLE ROLE FOR SEROTONIN AND NORADRENALINE [J].
REMINGTON, GJ .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1988, 8 (03) :228-229
[3]   CLINICAL CHARACTERISTICS OF THE PISA SYNDROME [J].
SUZUKI, T ;
KOIZUMI, J ;
MOROJI, T ;
SAKUMA, K ;
HORI, M ;
HORI, T .
ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 (06) :454-457
[4]   Effectiveness of anticholinergics and neuroleptic dose reduction on neuroleptic induced pleurothotonus (the Pisa syndrome) [J].
Suzuki, T ;
Hori, T ;
Baba, A ;
Abe, S ;
Shiraishi, H ;
Moroji, T ;
Piletz, JE .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (03) :277-280